Cleveland Biolabs (CBLI) Receives Several New U.S. Patents for Entolimod
Tweet Send to a Friend
Cleveland Biolabs (NASDAQ: CBLI) announced the issuance of several new patents for entolimod in the U.S. and other countries, further ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
